NCT05139134 is a clinical trial in Urinary Bladder Urothelial Carcinoma, sponsored by Sohag University.

Who is sponsoring NCT05139134?

NCT05139134 is sponsored by Sohag University.

What condition does NCT05139134 study?

NCT05139134 studies Urinary Bladder Urothelial Carcinoma.

Is NCT05139134 still recruiting?

NCT05139134 is currently status unknown. Last updated 29 July 2022.

Last reviewed 2022-07-29 · How we verify

NCT05139134

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Status unknown Last updated 29 July 2022

What this trial tests

trial in Urinary Bladder Urothelial Carcinoma in 50 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 May 2022

30 July 2022

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 January 2022
Primary completion	1 May 2022
Estimated completion	30 July 2022
Sites	1 location across Egypt

Conditions studied

Urinary Bladder Urothelial Carcinoma — all drugs for Urinary Bladder Urothelial Carcinoma →

Sponsor

Sohag University

Who can join

Eligibility, any sex, with Urinary Bladder Urothelial Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urothelial carcinoma is common malignant tumor worldwide, it remains a challenge in the oncology field, it is an ideal for research on biomarkers that could identify tumor progression and prognosis. CXCL5 have been implicated in progression of many cancers, but their significance in urinary bladder UC remains unclear.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Role of chemokine systems in cancer and inflammatory diseases.
Li H, Wu M, Zhao X. · · 2022 · cited 85× · PMID 35702353 · DOI 10.1002/mco2.147

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05139134 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 29 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing